CL2017001480A1 - Método de filtración - Google Patents

Método de filtración

Info

Publication number
CL2017001480A1
CL2017001480A1 CL2017001480A CL2017001480A CL2017001480A1 CL 2017001480 A1 CL2017001480 A1 CL 2017001480A1 CL 2017001480 A CL2017001480 A CL 2017001480A CL 2017001480 A CL2017001480 A CL 2017001480A CL 2017001480 A1 CL2017001480 A1 CL 2017001480A1
Authority
CL
Chile
Prior art keywords
filtration method
api
water
parasiticide
interval
Prior art date
Application number
CL2017001480A
Other languages
English (en)
Inventor
Elin Aksnes
Kathrin Ellesat
Kjersti Steinsvoll Rikardsen
Stian Brekke
Eddy Torp
Stanislas Baudouin
Original Assignee
Pharmaq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaq As filed Critical Pharmaq As
Publication of CL2017001480A1 publication Critical patent/CL2017001480A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/44Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
    • C02F1/444Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by ultrafiltration or microfiltration
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/44Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/52Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/5236Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using inorganic agents
    • C02F1/5245Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using inorganic agents using basic salts, e.g. of aluminium and iron
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00Nature of the contaminant
    • C02F2101/30Organic compounds
    • C02F2101/305Endocrine disruptive agents
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/20Nature of the water, waste water, sewage or sludge to be treated from animal husbandry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>SE REVELA UN MÉTODO PARA REDUCIR LA CONCENTRACIÓN DE UN INGREDIENTE ACTIVO FARMACÉUTICO (API) EN AGUA. EL API ES UN PARASITICIDA Y EL MÉTODO COMPRENDE FILTRAR EL AGUA AL USAR UN FILTRO QUE TIENE UN TAMAÑO DE POROS EN EL INTERVALO DE 0,1-7 UM.</p>
CL2017001480A 2014-12-10 2017-06-09 Método de filtración CL2017001480A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1421962.0A GB201421962D0 (en) 2014-12-10 2014-12-10 Filtration method

Publications (1)

Publication Number Publication Date
CL2017001480A1 true CL2017001480A1 (es) 2018-02-16

Family

ID=52425756

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001480A CL2017001480A1 (es) 2014-12-10 2017-06-09 Método de filtración

Country Status (7)

Country Link
EP (1) EP3230212B1 (es)
CA (1) CA2969602C (es)
CL (1) CL2017001480A1 (es)
DK (2) DK179923B1 (es)
ES (1) ES2764213T3 (es)
GB (1) GB201421962D0 (es)
WO (1) WO2016092050A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3747835A1 (en) 2019-06-03 2020-12-09 SUEZ Groupe Method and device to clean a treatment water containing a veterinary product for aquatic animals
EP4499578A1 (en) * 2022-03-24 2025-02-05 Zoetis Services LLC Degradation of hexaflumuron in ozonated sea water

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983605A (en) * 1986-10-23 1991-01-08 Ishihara Sangyo Kaisha Ltd. Pharmaceutical composition
US20090008318A1 (en) * 2006-12-04 2009-01-08 Prismedical Corporation Modular Water Purification and Delivery System
CN101665817B (zh) * 2009-09-28 2011-02-16 浙江升华拜克生物股份有限公司 阿维菌素发酵废水循环利用方法

Also Published As

Publication number Publication date
DK3230212T3 (da) 2020-01-06
GB201421962D0 (en) 2015-01-21
ES2764213T3 (es) 2020-06-02
CA2969602C (en) 2023-06-06
WO2016092050A1 (en) 2016-06-16
EP3230212A1 (en) 2017-10-18
CA2969602A1 (en) 2016-06-16
EP3230212B1 (en) 2019-11-06
DK201770437A1 (en) 2017-06-26
DK179923B1 (en) 2019-10-08

Similar Documents

Publication Publication Date Title
CL2015002865A1 (es) Composiciones de limpieza que contienen una poliéteramina
CL2016001120A1 (es) Compuestos derivados de pirrolo1,2-f1,2,4triazina ,composición farmacéutica que los comprende y su uso en el tratamiento de una infección por virus sincicial compuestos intermediarios. pct
EP3538078A4 (en) FORMULATIONS FOR EFFICIENT CANNABINOID DELIVERY
CO2017011535A2 (es) Composiciones de ácido obeticólico y métodos de uso
CL2015002891A1 (es) Deaza-purinonas macrocíclicas para el tratamiento de infecciones virales.
EA201690687A1 (ru) Ингибиторы репликации вируса иммунодефицита
MX2018007022A (es) Metodos para tratar la enfermedad de huntington.
EA201790266A1 (ru) Индолы для применения при инфекции, вызванной вирусом гриппа
EA201790630A1 (ru) Способы получения рибозидов
CL2015001916A1 (es) Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral.
EA201792613A1 (ru) Модуляторы cot и способы их применения
EA201691582A1 (ru) Новые фармацевтические препараты
BR112015011092A2 (pt) recuperação de soluto de extração e soluções de extração para processos de membrana direcionada osmoticamente
EA201690044A1 (ru) Модуляторы ядерного транспорта и их применение
CL2016002510A1 (es) 2-amino-6-metil-4,4a,5,6-tetrahidropirano [3,4-d][1,3] tiazin-8a(8h)-il-1,3-tiazol-4-ilamidas.
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
EP3313527A4 (en) PLANT VIRUS PARTICLES WITH AGGREGATE AGAINST CANCER
EA201691473A1 (ru) Биспецифические анти-il-13/il-17 антитела и их применение
EA201790571A1 (ru) Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа
DOP2016000253A (es) Nuevos compuestos
CO2017005500A2 (es) Método para la producción de un sistema de administración farmacéutica
SV2016005301A (es) Nuevos compuestos macrocíclicos
UA115373C2 (uk) Стабільний рідкий склад amg 416 (велкалсетиду)
EA201992832A1 (ru) Подкожное введение adamts13
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel